Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by beta-all-trans retinoic acid.
Vitamin A and some of its metabolites such as beta-all-trans retinoic acid (RA) have been implicated in the regulation of differentiation of normal and malignant epithelial cells in vivo and in vitro. In the present study the effects of RA on the growth and differentiation of 7 cell lines derived from human head and neck squamous-cell carcinomas (HNSCCs) were examined. RA (greater than 0.01 microM) inhibited the proliferation in monolayer culture of 6 of 7 HNSCC cell lines. One cell line (UMSCC-35) was very sensitive, 5 (UMSCC-10A, -19, -30, -22B and HNSCC 1483) were moderately sensitive, and 1 (HNSCC 183) was insensitive. Three of the cell lines (UMSCC-22B, -30, and HNSCC 1483) were capable of forming colonies in semisolid medium--a capability that was suppressed by RA. The HNSCC cell lines expressed various levels of the squamous-cell differentiation markers type I (particulate, epidermal) transglutaminase (TGase) and cholesterol sulfate (CS). RA treatment (I microM, 6 days) decreased TGase activity by more than 50% in 3 (UMSCC-10A, -22B and 1483) of the 7 cell lines, and the effect on UMSCC-22B was dose-dependent. Type II TGase (soluble, tissue type) activity was detected in 3 cell lines, and after RA treatment its activity increased in HNSCC 1483 and 183 cells and decreased in UMSCC-19. Following RA treatment, CS levels decreased by 20, 25, 70, 76, 89 and 91% in cell lines UMSCC-30, -10A, 183, UMSCC-35, -22B, and HNSCC 1483, respectively. The suppression by RA of CS accumulation in the 1483 cells was dose-dependent. Cholesterol sulfotransferase activity, which is responsible for CS synthesis, was suppressed by 40-97% after RA treatment of UMSCC-19, -22B, and HNSCC 1483. Our results demonstrate that RA inhibits the growth and decreases the level of 2 squamous differentiation markers in HNSCC cells.
Jetten
A M
AM
Laboratory of Pulmonary Pathobiology, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.
Kim
J S
JS
Sacks
P G
PG
Rearick
J I
JI
Lotan
D
D
Hong
W K
WK
Lotan
R
R
D002294:Carcinoma, Squamous Cell / Q000032:analysis / Q000201:enzymology / Q000473:pathology*; D002460:Cell Line / Q000032:analysis / Q000187:drug effects / Q000201:enzymology; D002471:Cell Transformation, Neoplastic / Q000032:analysis / Q000187:drug effects* / Q000473:pathology; D002788:Cholesterol Esters / Q000032:analysis; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D006258:Head and Neck Neoplasms / Q000032:analysis / Q000201:enzymology / Q000473:pathology*; D006801:Humans; D009062:Mouth Neoplasms / Q000032:analysis / Q000201:enzymology / Q000473:pathology; D015238:Sulfotransferases / Q000032:analysis; D011503:Transglutaminases / Q000032:analysis; D014212:Tretinoin / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000032:analysis / Q000187:drug effects / Q000201:enzymology
D002788:Cholesterol Esters; D014212:Tretinoin; D011503:Transglutaminases; D015238:Sulfotransferases; C043456:cholesterol sulfotransferase; C007045:cholesteryl sulfate